Dr. Gobind Singh Kapkoti

Collaborator
DISC Type : si

Director-R&D, CDMO at Piramal Pharma Solutions

Hyderabad, Telangana, India

Overview

Dr. Gobind Singh Kapkoti is a performance-driven synthetic organic chemist with 30 years of industrial experience in the pharmaceutical sector. He currently serves as the Director of R&D for CDMO at Piramal Pharma Solutions, leading late-phase project development. Colleagues describe him as creative, knowledgeable, result-oriented, and a true team player with strong leadership skills.

While his public profile is focused on his extensive scientific career, he has shared a personal sentiment about the importance of helping those in need, suggesting an interest in philanthropy or community support. He also follows developments at major pharmaceutical companies like Pfizer and Merck.

He has successfully developed non-infringing processes for over 60 APIs and has filed more than 30 patents throughout his distinguished career.

Personality Overview

Example Driven

Consensus Builder

Good Listener

Unlike D or C types, they are calm as well as friendly and can give the impression of being more receptive than they actually are.  Win-win scenarios can appeal strongly to them. They are more likely to go for proven solutions.

Topics They Care About

API & CDMO Development
Holds 30 years of experience leading Process Research, Scale-up, and Technology Transfer for API, NCEs, and CDMO projects at companies like Piramal, Intas, and Jubilant.
Process Innovation
Focuses on creating cost-effective, commercially viable, and IP-compliant processes. He has developed over 60 API processes and filed more than 30 patents.
R&D Leadership
Has a long history of managing and heading R&D departments, responsible for technical operations and leading teams to deliver on complex projects against strict timelines.

Media Appearances

Dr. has no verified media appearances

Work History

1-2021
Director-R&D, CDMO at Piramal Pharma Solutions
5-2018 - 6-2020
Director - Technical at Sachi-Chem Industries Private Limited
8-2014 - 4-2018
Head - API (R&D) at Intas Pharmaceuticals
9-2011 - 8-2014
Head - R&D & Pilot Plant (CDMO) at Jubilant Life Sciences Ltd
9-2010 - 9-2011
General Manager and Head Chemical R&D (CDMO) at Amrutanjan Health Care Limited

Education

Leadership and Management from Indian Institute of Management, Calcutta
Doctor of Philosophy (Ph.D.) from Kumaun University, Nainital

More Information

Social Presence :

Prographics :

Exp : 30 Location : Hyderabad, Telangana, India Job Level : N/A Designation : Director-R&D, CDMO at Piramal Pharma Solutions
URL has been copied!

Insights For Selling To Dr. Gobind Singh

During A Call Or A Meeting

DO's

  • Use testimonials, case studies to show them why it is a low-risk, high-value decision
  • If possible, involve their colleagues in the sales process
  • Summarize the key points at the end of the conversation

DONT's

  • Don’t push them to make decisions very fast, let them take their time
  • Don’t give the impression of being unproven or risky
  • Don’t get into excessive details unless prompted

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Dr. Gobind Singh is

  • Relationship and rapport play a major role, followed by low risk and the presence of proof points.
  • Will you ever get a clear answer from Dr. Gobind Singh

  • They are diplomatic when the need arises; they hardly ever say a direct no.

Insights For Deal Planning

    How fast (or slow) will Dr. Gobind Singh move?

  • They can take their time to reach decisions, even while they stay engaged and friendly.
  • Can Dr. Gobind Singh take some risk or not?

  • They are unlikely to take many risks.

You And Dr. Gobind Singh

Personality Compatibility


Other Piramal Pharma Solutions Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.